Summary
High oral doses of mebendazole have been only partly effective in the treatment of patients with alveolar or cystic echinococcosis. In order to improve therapeutic results the pharmacology of mebendazole has been investigated. Jirds experimentally infected with larval Echinococcus multilocularis were given food containing mebendazole 100 to 1000 ppm. Drug plasma concentrations above 0.25 µmol/l were associated with a reduction in parasite weight to 1 to 10% of that in untreated controls. In treated animals parasite weight was negatively correlated with the plasma mebendazole concentration and with the duration of therapy. In patients on long term therapy with similar doses of mebendazole (16 to 48 mg/kg per day), plasma concentrations were much lower than in jirds. Only 19% of fasting plasma concentrations exceeded 0.25 µmol/l. Plasma concentrations 4 h after the morning dose did not exceed this value in 48% of cases. The results can be explained by the irregular drug absorption and short plasma half life observed in 7 hospitalized patients. It is likely that better results would be obtained if doses of mebendazole were adjusted to produce peak plasma levels exceeding 0.25 µmol/l.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Akovbiantz A, Eckert J, Hess U, Schmid M (1977) Clinical experience with mebendazole treatment of human echinococcosis. Proceedings of International Congress of Hydatidosis. Athens
Al-Moslih MI, Al-Rawas AY, Rassam S, Al-Dabagh MA, Al-Janari TA, Shafik MA, Al-Ani MS (1978) Treatment of hydatidosis. Br Med J 2: 1435
Ammann R, Akovbiantz A, Eckert J (1979a) Chemotherapie der Echinokokkose des Menschen mit Mebendazol (Vermox®). Vorläufige klinische Erfahrungen. Schweiz Med Wochenschr 109: 148–151
Ammann R, Akovbiantz A, Eckert J, Largiadèr F (1979b) Therapie der Echinokokkose. Dtsch Med Wochenschr 104: 1429–1431
Beard TC, Rickard MD, Goodman HT (1978) Medical treatment for hydatids. Med J Aust 1: 633–635
Bekhti A, Schaaps JP, Capron M, Dessaint JP, Santoro F, Capron A (1977) Treatment of hepatic hydatid disease with mebendazole: preliminary results in four cases. Br Med J 2: 1047–1051
Bekhti A, Nizet M, Capron M, Dessaint JP, Santoro F, Capron A (1980) Chemotherapy of human hydatid disease with mebendazole. Follow up of 16 cases. Acta Gastroenterol Belg 43: 48–65
Brandimarte C, Attili AF, Cantafora A, De Martin GL, Giunchi G (1980) Serum and hydatid cystic fluid levels of mebendazole in patients with liver hydatidosis. Ital J Gastroenterol 12: 212–213
Brugmans JP, Thienpont DC, Van Wijngaarden I, Vanparijs OF, Schuermans VL, Lauwers HL (1971) Mebendazole in enterobiasis. Radiochemical and pilot clinical study in 1278 subjects. JAMA 217: 313–316
Burkhardt B (1981) Beiträge zur experimentellen Chemotherapie der larvalen Echinokokkose mit Untersuchungen zur biologischen Verfügbarkeit von Mebendazol bei Nagetieren. Thesis, University of Zürich
Eckert J, Pohlenz J (1976) Zur Wirkung von Mebendazol auf Metazestoden von Mesocestoides corti und Echinococcus multilocularis. Tropenmed Parasitol 27: 247–262
Eckert J, Barandun G, Pohlenz J (1978) Chemotherapie der larvalen Echinokokkose bei Labortieren. Schweiz Med Wochenschr 108: 1104–1112
Eckert J (1980a) Neue Medikamente gegen Echinokokkose. In: Gsell OG (ed) Importierte Infektionskrankheiten. Epidemiologie und Therapie. Georg Thieme, Stuttgart, pp 136–140
Eckert J (1980b) Experimental chemotherapy of larval echinococcosis in laboratory animals. Workshop “Chemotherapy of Larval Echinococcosis”, Beerse, November 24–25, 1980
Eckert J, Burkhardt B (1980) Chemotherapy of experimental echinococcosis. Acta Trop 37: 297–300
Goodman HT (1976) Mebendazole. Med J Aust 2: 662
Karlaganis G, Münst GJ, Bircher J (1979) High pressure liquid chromatographic determination of the anthelmintic drug mebendazole in plasma. J High Resolut Chromatogr Commun 2: 141–144
Kasai Y, Koshino I, Kawanishi N, Sakamoto H, Sasaki E, Kumagai M (1980) Alveolar echinococcosis of the liver. Studies on 60 operated cases. Ann Surg 191: 145–152
Kayser HJS (1980) Treatment of hydatid disease with mebendazole at Frere Hospital, East London. A preliminary report. S Afr Med J 58: 560–563
Kern P, Dietrich M, Volkmer KJ (1979) Chemotherapy of echinococcosis with mebendazole. Clinical observations of 7 patients. Tropenmed Parasitol 30: 65–72
Kroidl R, Amthor M, Wagemann W, Kronenberger H, Meier-Sydow J (1978) Ungewöhnliche klinische und morphologische Präsentation einer Lungenechinokokkose. Prax Pneumol 32: 200–203
Lüdin CE, Gyr K, Karoussos K (1977) Therapy of alveococcosis in man. J Intern Med Res 5: 367–368
Mosimann F (1980) Is alveolar hydatid disease of the liver incurable? Ann Surg 192: 118–123
Münst GJ, Karlaganis G, Bircher J (1980) Plasma concentrations of mebendazole during treatment of echinococcosis. Preliminary results. Eur J Clin Pharmacol 17: 375–378
Schicker HJ (1976) Die Echinokokkose des Menschen. Stand von Diagnose, Therapie und Prognose bei Echinokokkenerkran-kungen in Baden-Württemberg in den Jahren 1960 bis 1972. Thesis, University of Tübingen
Starke J (1979) Die konservative Behandlung des Echinococcus alveolaris der Leber. Dtsch Med Wochenschr 104: 1132–1135
Werczberger A, Golhman J, Wertheim G, Gunders AE, Chowers I (1979) Disseminated echinococcosis with repeated anaphylactic shock. Treated with mebendazole. Chest 74: 482–484
Wilson JF, Davidson M, Rausch RL (1978) A clinical trial of mebendazole in the treatment of alveolar hydatid disease. Am Rev Respir Dis 118: 747–757
Author information
Authors and Affiliations
Additional information
Dr. Witassek is in receipt of a stipend from the Deutsche Forschungsgemeinschaft (Wi 579/1)
Rights and permissions
About this article
Cite this article
Witassek, F., Burkhardt, B., Eckert, J. et al. Chemotherapy of alveolar echinococcosis. Eur J Clin Pharmacol 20, 427–433 (1981). https://doi.org/10.1007/BF00542095
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00542095